12 completed. 12 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 12 | Completed 12 |
Follow Glipizide: new trials by email Literature Review of Glipizide trials Research Report on Glipizide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus With Chronic Kidney Disease or Kidney Failure on Dialysis (MK-3102-019) Omarigliptin, Placebo to omarigliptin, Glipizide - Type 2 Diabetes Mellitus | Phase 3 | Completed | Merck Sharp & Dohme LLC | 213 | 2012-10-02 | 2018-08-09 |
| Sitagliptin (MK-0431) vs. Placebo in Patients With Inadequate Glycemic Control on Metformin With Pioglitazone (MK-0431-128) Sitagliptin, Comparator: Placebo, Pioglitazone - Type 2 Diabetes Mellitus | Phase 3 | Completed | Merck Sharp & Dohme LLC | 313 | 2009-04-15 | 2017-05-23 |
| Efficacy and Safety of Alogliptin Plus Metformin Compared to Glipizide Plus Metformin in Patients With Type 2 Diabetes Mellitus Alogliptin, Metformin, Glipizide - Type 2 Diabetes Mellitus | Phase 3 | Completed | Takeda | 2639 | 2009-03-01 | 2013-12-03 |
| Efficacy and Safety of Alogliptin Compared to Glipizide in Elderly Diabetics Alogliptin, Glipizide - Diabetes Mellitus | Phase 3 | Completed | Takeda | 441 | 2008-06-01 | 2013-05-24 |
| Efficacy and Safety of Dapagliflozin in Combination With Metformin in Type 2 Diabetes Patients dapagliflozin, glipizide, metformin hydrochloride - Type 2 Diabetes | Phase 3 | Completed | AstraZeneca | 1217 | 2008-03-01 | 2015-03-30 |
| Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and End-Stage Renal Disease (MK-0431-073 AM1) Sitagliptin, Glipizide - Diabetes Mellitus, Type 2, End-Stage Kidney Disease | Phase 3 | Completed | Merck Sharp & Dohme LLC | 129 | 2007-10-19 | 2017-05-12 |
| Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (MK-0431-063 AM1) Sitagliptin, Glipizide, Placebo for Sitagliptin - Diabetes Mellitus, Type 2, Renal Insufficiency, Chronic | Phase 3 | Completed | Merck Sharp & Dohme LLC | 426 | 2007-10-09 | 2017-05-12 |
| Sitagliptin Metformin/PPARg Agonist Combination Therapy Add-on (0431-052) sitagliptin, Comparator: Placebo, rosiglitazone - Type 2 Diabetes Mellitus | Phase 3 | Completed | Merck Sharp & Dohme LLC | 262 | 2006-06-12 | 2017-05-12 |
| Rosiglitazone Versus a Sulfonylurea On Progression Of Atherosclerosis In Patients With Heart Disease And Type 2 Diabetes Glipizide, rosiglitazone maleate - Atherosclerosis | Phase 3 | Completed | GlaxoSmithKline | 672 | 2005-01-01 | 2017-03-23 |
| An Investigational Drug in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (0431-028)(COMPLETED) sitagliptin, Placebo to Sitagliptin, glipizide - Diabetes Mellitus, Type 2, Chronic Renal Insufficiency | Phase 3 | Completed | Merck Sharp & Dohme LLC | 91 | 2004-10-01 | 2015-04-02 |
| An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (0431-024) sitagliptin (MK0431), Comparator: glipizide - Diabetes Mellitus, Type 2 | Phase 3 | Completed | Merck Sharp & Dohme LLC | 1172 | 2004-09-01 | 2016-08-26 |
| Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-020)(COMPLETED) Sitagliptin (MK0431), Placebo/Glipizide 5 mg, Metformin - Diabetes Mellitus, Type II | Phase 3 | Completed | Merck Sharp & Dohme LLC | 701 | 2004-06-30 | 2017-05-05 |
Diabetes Mellitus, Type 2 (11) · Diabetes Mellitus (2) · Renal Insufficiency, Chronic (2) · Atherosclerosis (1) · Dyslipidemias (1) · Glucose Intolerance (1) · Glucose Metabolism Disorders (1) · Hyperglycemia (1) · Hyperinsulinism (1) · Kidney Failure, Chronic (1) · Plaque, Atherosclerotic (1)
Merck Sharp & Dohme LLC (8) · Takeda (2) · AstraZeneca (1) · GlaxoSmithKline (1)
Mexico (4) · Argentina (3) · Germany (3) · India (3) · Italy (3) · Poland (3) · Russia (3) · South Africa (3) · Spain (3) · United States (3) · Brazil (2) · Canada (2) · France (2) · Hong Kong (2) · Hungary (2)
Michael A. Nauck, Prof. Dr. med. (1)
PMID 20194881, PMID 20456211, PMID 21477878, PMID 21816980, PMID 22742523, PMID 23116881, PMID 23248197, PMID 23352379, PMID 23529570, PMID 25633134, PMID 27787778, PMID 28449320
2008 (2)